Clonal distribution and molecular characterization of isolated strains in Chania and Heraklion, Crete.

Aim: This study investigates the demographic distribution, antibiotic resistance profiles, and molecular characteristics of infections.

Methods: The study was carried out in 141 patients, 60.4% male, in patients from Chania and Heraklion, Crete.

A Comparative Analysis of MRSA: Epidemiology and Antibiotic Resistance in Greece and Romania.

This study provides a comparative analysis of 243 Methicillin-resistant (MRSA) isolated strains from Greece and Romania, focusing on their epidemiology and antibiotic resistance patterns. Laboratory procedures included phenotypic and automated identification methods, susceptibility testing, DNA isolation, and PCR for detecting antibiotic resistance genes (, ). Our study results show significant regional differences.

Isovolumetric Contraction as a Marker of Ventricular Performance in Patients with Afterload Mismatch.

Introduction: The evaluation of myocardial contractility is essential in cardiology practice. The gold standard for this evaluation is the end-systolic elastance, but it the method involved is complex. Echocardiographic measurement of the ejection fraction (EF) is the most commonly used parameter in clinical practice, but it has significant limitations, especially in patients with afterload mismatch.

Examining the Prevalence and Antibiotic Susceptibility of Strains in Hospitals: An Analysis of the Gene and Its Co-Occurrence with Other Virulence Factors.

is a pathogenic bacterium that causesinfections. Its virulence is due to surface components, proteins, virulence genes, , , , and , which are low molecular weight superantigens. are usually encoded by mobile genetic elements, and horizontal gene transfer accounts for their widespread presence in .

ABREAST: a prospective, real-world study on the effect of nab-paclitaxel treatment on clinical outcomes and quality of life of patients with metastatic breast cancer.

Purpose: The efficacy of nab-paclitaxel in patients with metastatic breast cancer (MBC) has been demonstrated in randomized clinical trials. However, real-world evidence on effectiveness remains limited.

Patients And Methods: The primary objective of this multicenter prospective study was to assess the overall response rate (ORR) of patients with MBC treated with nab-paclitaxel.